DERMAN ANTIFUNGAL CREAM- tolnaftate cream 
Taisho Pharmaceutical California Inc.

----------

Derman antifungal cream

Drug Facts

Active ingredient

Tolnaftate 1%

Purpose

Antifungal

Uses

Warnings

Do not use

on children under 2 years of age unless directed by a doctor.

For external use only.

Avoid contact with eyes.

Stop use and ask a doctor if 

  • irritation occurs
  • there is no improvement within 4 weeks for athlete's foot and ringworm or 2 weeks for jock itch

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away: 800-222-1222.

Directions

Other information

store at 15 to 30°C (59° to 86°F)

DO NOT USE IF SEAL ON TUBE IS PUNCTURED OR MISSING. Tamper Evident:

Inactive ingredients

ceteth-20, cetyl alcohol, chlorocresol, mineral oil, monobasic sodium phosphate, petrolatum, propylene glycol, purified water, stearyl alcohol

Package Labeling:25g

box

tube

Package Labeling:50g

box50

tube50

DERMAN ANTIFUNGAL CREAM 
tolnaftate cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:81929-004
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE10 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
CETETH-20 (UNII: I835H2IHHX)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
CHLOROCRESOL (UNII: 36W53O7109)  
MINERAL OIL (UNII: T5L8T28FGP)  
SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM (UNII: 3980JIH2SW)  
PETROLATUM (UNII: 4T6H12BN9U)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
WATER (UNII: 059QF0KO0R)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:81929-004-021 in 1 CARTON07/01/2022
125 g in 1 TUBE; Type 0: Not a Combination Product
2NDC:81929-004-011 in 1 CARTON07/01/2022
250 g in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00507/01/2022
Labeler - Taisho Pharmaceutical California Inc. (603827635)

Revised: 11/2023
Document Id: 09ce6831-6c39-8029-e063-6394a90a2feb
Set id: 15d9b3c9-01af-4083-a1bc-014505d8798d
Version: 3
Effective Time: 20231110
 
Taisho Pharmaceutical California Inc.